A Founder Looks at 50: Following Our Big Election Day Victories, It’s Time to Look Forward to 2021

Ironically, the marijuana legalization issue, which was a “hot button” political issue for decades, the discussion of which could almost be guaranteed to destroy a Thanksgiving dinner with extended family, may now become fertile common ground where those of us who may not agree on some other important issues, nonetheless can congregate and begin to rebuild a sense of community.
The post A Founder Looks at 50: Following Our Big Election Day Victories, It’s Time to Look Forward to 2021 appeared first on NORML.

5 questions for hemp businesses from the election results – and 1 big reason for optimism

The nail-biter 2020 presidential election in the United States has a lot of folks scratching their heads. The hemp industry is no exception. Though the presidential campaigns never talked about the the newly legal crop, the race set up enormous implications for the business landscape faced by the hemp industry. That’s because the main regulators […]

Hemp industry pushing DEA to address byproducts

The Hemp Industries Association and a South Carolina CBD maker are trying to get U.S. Drug Enforcement Administration to clarify whether it considers temporary byproducts of hemp production a Schedule 1 substance. In a filing Monday in U.S. District Court in Washington DC, HIA and RE Botanicals ask a judge to order the DEA to […]

Prominent CBD advocate in US House loses re-election

House Agriculture Chairman Collin Peterson, a Minnesota Democrat and sponsor of a bill to require federal food and agriculture regulators to treat hemp-derived CBD as a dietary supplement, has lost his re-election bid. Peterson lost to Republican challenger Michelle Fischbach on Tuesday. He has represented rural western Minnesota since 1991; demographic changes made him among […]

Should ‘broad-spectrum’ CBD be defined? What about ‘isolate’? NY’s new extract rules could be model for nation

CBD consumers trying to make sense of terms like “full spectrum” and “broad spectrum” on labels are getting some help in New York state, where new rules for hemp extracts are winning praise from some in the hemp industry who say they could serve as a template for future state or federal action. Hemp operators […]

Epidiolex maker GW Pharma reports record quarterly revenue of $137 million

(A version of this story first appeared at Marijuana Business Daily.) United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex. GW’s total revenue for the third quarter reached $137.1 million, about 16% more than the previous quarter’s $121.3 million. Epidiolex sales […]

1 91 92 93 94 95 197
Right Menu Icon